Director Simeon George Reports a $51 Million $CRSP Buy

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 CRISPR Therapeutics $CRSP – Director Simeon George just dropped a monster $51 million via a Form 4.

That’s one of the largest biotech insider buys we’ve seen all year and a major vote of confidence in gene-editing as a long-term theme.

Here’s The Hot Corner, with data from July 17, 2025:

Click the table to enlarge it.

📌 Angiodynamics $ANGO – Point72 just disclosed a fresh 5.20% stake in $ANGO via an original 13G filing.

When a major player like Point72 moves in with a significant passive stake, it’s worth paying attention.